HALO logo
halo search icon
BioAge Labs, Inc.

US$16.11

Price Change Indicator
-0.26 (-1.588%)
BioAge Labs, Inc.
BIOA · NAS

BioAge Labs, Inc.

Start Trading BIOA for Free

US$16.11

Price Arrow-0.26 (-1.588%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BioAge Labs, Inc. Overview

BIOA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BIOA

icon

Website

BioAge Labs, Inc.

icon

Telephone

1.510.806.1445

icon

Address

Suite 370, 5885 Hollis Street, Emeryville, CA 94608

Description

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

BIOA Price Chart

Key Stats

Market Cap

US$727.69M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.79 - 24

Trade Value (12mth)

US$1,456,505.00

1 week

-7.3%

1 month

-16.52%

YTD

27.59%

1 year

319.74%

All time high

26.62

Key Fundamentals

EPS 3 yr Growth

92.90%

EBITDA Margin

NaN%

Operating Cashflow

-$82m

Free Cash Flow Return

-27.20%

ROIC

-26.90%

Interest Coverage

-132.80

Quick Ratio

14.20

Other Data

Shares Outstanding (Fully Diluted)

42m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BIOA Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
25 March 26

BIOA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.87-1.98-2.24locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.87-1.98-2.24locklocklock
Growth
 %locklocklocklock-60.6-6.2-13.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of BioAge Labs, Inc. (BIOA:NAS)?
Halo FAQ
The current share price of BioAge Labs, Inc. (BIOA:NAS) is USD$16.11.
What is the 52-week high share price for BioAge Labs, Inc. (BIOA:NAS)?
Halo FAQ
The 52-week high share price for BioAge Labs, Inc. (BIOA:NAS) is USD$24.00.
What is the 52-week low share price for BioAge Labs, Inc. (BIOA:NAS)?
Halo FAQ
The 52-week low share price for BioAge Labs, Inc. (BIOA:NAS) is USD$3.79.
What is the dividend yield for BioAge Labs, Inc. (BIOA:NAS)?
Halo FAQ
BioAge Labs, Inc. (BIOA:NAS) does not pay a dividend.
What was BioAge Labs, Inc. (BIOA:NAS) last dividend payment?
Halo FAQ
BioAge Labs, Inc. (BIOA:NAS) does not pay a dividend.
What is the franking level for BioAge Labs, Inc. (BIOA:NAS)?
Halo FAQ
BioAge Labs, Inc. (BIOA:NAS) has a franking level of 0.00%.
In which sector is BioAge Labs, Inc. (BIOA:NAS) classified?
Halo FAQ
BioAge Labs, Inc. (BIOA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial